Peptides for Gut Health

Gut Health Peptide Therapy Overview

Peptide therapy for gut health centers on BPC-157, a pentadecapeptide originally isolated from human gastric juice. It promotes gut mucosal healing, reduces inflammation, and supports the gut-brain axis. KPV is an anti-inflammatory tripeptide showing promise for inflammatory bowel conditions.

• Gut mucosal lining repair
• Reduced intestinal inflammation
• Improved leaky gut symptoms
• Support for IBS and IBD management
• Gut-brain axis optimization

How Gut Health Peptides Work

Gut healing peptides restore intestinal barrier integrity through multiple mechanisms. BPC-157 promotes angiogenesis in the gut mucosa, increasing blood supply to damaged intestinal lining. It modulates the nitric oxide system, which is critical for gut motility and mucosal defense. It also influences the gut-brain axis via the vagus nerve, which is why it can improve both GI symptoms and mood simultaneously. KPV is a tripeptide (Lys-Pro-Val) derived from alpha-MSH that potently inhibits NF-kB inflammatory signaling in intestinal epithelial cells and immune cells — the same pathway overactivated in Crohn's disease and ulcerative colitis. LL-37 provides direct antimicrobial defense against pathogenic bacteria, fungi, and biofilms while preserving beneficial gut flora, making it useful for SIBO and dysbiosis.

Peptides Used for Gut Health

Who Is Gut Health Peptide Therapy For?

Gut health peptide therapy is appropriate for patients with IBS (irritable bowel syndrome), IBD (Crohn's, ulcerative colitis) as adjunct therapy, leaky gut / intestinal hyperpermeability, SIBO (small intestinal bacterial overgrowth), chronic gastritis, or NSAID-induced gut damage. It's also used by patients whose gut issues are driving systemic symptoms — fatigue, brain fog, skin conditions, autoimmunity — via the gut-immune and gut-brain axes. Not a replacement for IBD medications like biologics; best used as complementary therapy under supervision.

Gut health protocols uniquely benefit from oral delivery. BPC-157 can be taken as oral capsules (500mcg on an empty stomach, 1–2x daily) for direct gut mucosal contact, or as SC injections (250–500mcg/day) for systemic gut-brain axis support. Many providers use both simultaneously. KPV is often compounded as oral capsules or suppositories for IBD patients. LL-37 is typically SC injection (100mcg/day for 2–4 weeks) for SIBO/dysbiosis. Protocol duration is 8–12 weeks minimum, as gut mucosal healing is gradual. Providers recommend concurrent support: L-glutamine, bone broth, probiotics, and elimination of inflammatory foods. Labs include stool analysis (GI-MAP), lactulose breath test (SIBO), and inflammatory markers (calprotectin, hsCRP).

Gut Health Peptide News

News aggregated via Google News. Inclusion does not imply endorsement.

Gut Health Guides & Resources

Gut Health Peptide FAQs